During the past decade, Albert Schweitzer ziekenhuis conducted 101 clinical trials. In the 10-year time frame, 101 clinical trials started and 30 clinical trials were completed, i.e. on average, 29.7% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 18 clinical trials were completed. i.e. 41.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Albert Schweitzer ziekenhuis" #1 sponsor was "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 9 trials, followed by "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 7 trials sponsored, "Erasmus Medical Center" with 7 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored and "Janssen Research & Development, LLC" with 7 trials sponsored. Other sponsors include 103 different institutions and companies that sponsored additional 74 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Albert Schweitzer ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 9 trials as a collaborator, "Albert Schweitzer Hospital" with 8 trials as a collaborator, "Erasmus Medical Center" with 7 trials as a collaborator, "Maastricht University Medical Center" with 5 trials as a collaborator and "Amphia Hospital" with 4 trials as a collaborator. Other collaborators include 182 different institutions and companies that were collaborators in the rest 152 trials.

According to Clinical.Site data, the most researched conditions in "Albert Schweitzer ziekenhuis" are "Coronary Artery Disease" (8 trials), "Atrial Fibrillation" (5 trials), "Breast Cancer" (5 trials), "Colorectal Cancer" (5 trials) and "Breast Neoplasms" (4 trials). Many other conditions were trialed in "Albert Schweitzer ziekenhuis" in a lesser frequency.

Most popular intervention types in "Albert Schweitzer ziekenhuis" are "Drug" (86 trials), "Device" (25 trials), "Other" (18 trials), "Procedure" (15 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Obinutuzumab" (5 trials), "Apixaban" (4 trials), "Ibrutinib" (4 trials) and "Venetoclax" (4 trials). Other intervention names were less common.

The vast majority of trials in "Albert Schweitzer ziekenhuis" are 130 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 72 active trials in "Albert Schweitzer ziekenhuis". 2 are not yet recruiting, 37 are recruiting, 30 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 46 completed trials in Albert Schweitzer ziekenhuis, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Albert Schweitzer ziekenhuis, 2 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 32 trials that are defined as “Not Applicable".

Albert Schweitzer ziekenhuis has several departments that took part in Clinical trials: "Albert Schweitzer Hospital, Cardiology" - 2 trials